# NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
> **ANDA204920** · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2021-07-20
## Drug
- **FDA Application Number:** ANDA204920
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
- **Generic name:** Esomeprazole Magnesium
- **Active ingredients:** ESOMEPRAZOLE MAGNESIUM; NAPROXEN
- **Dosage form:** TABLET, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PHARMOBEDIENT
- **First approval:** 2021-07-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204920)
---
*MORVS · CC0 1.0*